[HTML][HTML] Transdermal testosterone treatment in women with impaired sexual function after oophorectomy
JL Shifren, GD Braunstein, JA Simon… - … England Journal of …, 2000 - Mass Medical Soc
Background The ovaries provide approximately half the circulating testosterone in
premenopausal women. After bilateral oophorectomy, many women report impaired sexual …
premenopausal women. After bilateral oophorectomy, many women report impaired sexual …
Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children.
LM Pachman, JR Hayford, A Chung… - The Journal of …, 1998 - europepmc.org
Objective To evaluate demographic and clinical characteristics, duration of time between
disease onset (date of first rash and/or weakness), and diagnosis/therapy, as well as …
disease onset (date of first rash and/or weakness), and diagnosis/therapy, as well as …
Efficacy of Glucarpidase (Carboxypeptidase G 2) in Patients with Acute Kidney Injury After High‐Dose Methotrexate Therapy
BC Widemann, S Schwartz… - … : The Journal of …, 2014 - Wiley Online Library
Study Objective Because the incidence rate of renal impairment is 2–10% for patients
treated with high‐dose methotrexate and renal impairment develops in 0–12.4% of patients …
treated with high‐dose methotrexate and renal impairment develops in 0–12.4% of patients …
Medically significant late bleeding after treated crotaline envenomation: a systematic review
EJ Lavonas, V Khatri, C Daugherty… - Annals of emergency …, 2014 - Elsevier
Study objective We estimate the proportion of patients with crotaline snake envenomation
who are treated with Crotalidae polyvalent immune Fab (ovine) antivenom and who develop …
who are treated with Crotalidae polyvalent immune Fab (ovine) antivenom and who develop …
Prognostic factors for functional outcome of total knee replacement: a prospective study
L Sharma, J Sinacore, C Daugherty… - The Journals of …, 1996 - academic.oup.com
Background. The objective was to investigate whether baseline physical functioning,
medical, psychosocial, or demographic variables predict functional outcome in patients …
medical, psychosocial, or demographic variables predict functional outcome in patients …
Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study
K Miller, C Corcoran, C Armstrong… - The Journal of …, 1998 - academic.oup.com
abstract Although human immunodeficiency virus (HIV) disease is increasing rapidly among
women, no prior studies have investigated gender-based therapeutic strategies for the …
women, no prior studies have investigated gender-based therapeutic strategies for the …
Relationship between patient-reported symptoms, limitations in daily activities, and psychological impact in varicose veins
R Mallick, BK Lal, C Daugherty - Journal of Vascular Surgery: Venous and …, 2017 - Elsevier
Objective The objective of this study was to evaluate the relationship between patient-
reported symptoms, functional limitations, and psychological impact of varicose veins (VVs) …
reported symptoms, functional limitations, and psychological impact of varicose veins (VVs) …
A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high‐dose methotrexate therapy in open‐label …
KA Janeway, L Gros, S Schwartz… - Pediatric Blood & …, 2023 - Wiley Online Library
Background Delayed methotrexate elimination can occur in patients undergoing high‐dose
methotrexate cancer treatment. Effectiveness of glucarpidase for rapidly reducing …
methotrexate cancer treatment. Effectiveness of glucarpidase for rapidly reducing …
New‐onset juvenile dermatomyositis. Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis
LM Pachman, JR Hayford, MC Hochberg… - … : Official Journal of …, 1997 - Wiley Online Library
Objective. To determine, in a case‐control study, if patients with new‐onset juvenile
dermatomyositis (juvenile DM) have increased symptoms prior to onset, exposure to certain …
dermatomyositis (juvenile DM) have increased symptoms prior to onset, exposure to certain …
[HTML][HTML] Total CroFab and Anavip antivenom vial administration in US rattlesnake envenomations: 2019–2021
N Brandehoff, A Dalton, C Daugherty, RC Dart… - Journal of Medical …, 2023 - Springer
Abstract Introduction In 2018, Anavip became available for the treatment of rattlesnake
envenomations in the USA. No comparisons between the treatment characteristics of …
envenomations in the USA. No comparisons between the treatment characteristics of …